# |
View Form |
|
Insider Title |
Company Name |
Ticker |
Trans Type |
Dollar Value |
Shares Traded |
Trans Date From |
Trans Date To |
Trans Price From |
Trans Price To |
Total Holdings |
Delta % Owned |
Owned |
Other Info |
SIC Code |
SIC Sector |
SIC Industry |
SIC Sub-Industry |
Input Date | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
CEO,DIR |
OS |
$12,114,155 |
160,773 |
3/9/26 |
3/10/26 |
$74.11 |
$76.34 |
242,662 |
-39.9 |
D |
10b |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
3/11/26 - 4:19:03 pm | ||||||||||||||
2 |
CEO,DIR |
OE |
$9,039,364 |
148,454 |
3/9/26 |
3/10/26 |
--- |
$60.89 |
369,332 |
67.2 |
D |
10b |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
3/11/26 - 4:19:03 pm | ||||||||||||||
3 |
CEO,DIR |
JB |
$23,651 |
484 |
--- |
2/27/26 |
--- |
$48.87 |
254,981 |
0.2 |
D |
--- |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
3/3/26 - 5:28:55 pm | ||||||||||||||
4 |
CEO,DIR |
AS |
$2,524,820 |
29,430 |
--- |
2/6/26 |
--- |
$85.79 |
254,497 |
-10.4 |
D |
10b |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
2/10/26 - 5:04:29 pm | ||||||||||||||
5 |
CEO,DIR |
S |
$5,208,979 |
62,970 |
--- |
1/30/26 |
--- |
$82.72 |
283,927 |
-18.2 |
D |
R |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
2/2/26 - 8:51:49 pm | ||||||||||||||
6 |
CEO,DIR |
JB |
--- |
122,214 |
--- |
1/29/26 |
--- |
--- |
346,897 |
54.4 |
D |
R |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
2/2/26 - 8:51:49 pm | ||||||||||||||
7 |
CEO,DIR |
S |
$3,294,624 |
44,034 |
--- |
1/16/26 |
--- |
$74.82 |
224,683 |
-16.4 |
D |
R |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
1/20/26 - 8:20:23 pm | ||||||||||||||
8 |
CEO,DIR |
JB |
--- |
89,145 |
--- |
1/15/26 |
--- |
--- |
268,717 |
49.6 |
D |
R |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
1/20/26 - 8:20:23 pm | ||||||||||||||
9 |
CEO,DIR |
AS |
$30,268 |
437 |
--- |
10/6/25 |
--- |
$69.26 |
179,572 |
-0.2 |
D |
10b |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
10/8/25 - 6:36:54 pm | ||||||||||||||
10 |
CEO,DIR |
OS |
$12,294,703 |
203,814 |
--- |
9/3/25 |
$59.12 |
$61.06 |
180,009 |
-53.1 |
D |
10b |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
9/4/25 - 8:38:20 pm | ||||||||||||||
11 |
CEO,DIR |
OE |
$9,032,039 |
203,814 |
--- |
9/3/25 |
--- |
$32.60 |
308,324 |
195.0 |
D |
10b |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
9/4/25 - 8:38:20 pm | ||||||||||||||
12 |
CEO,DIR |
JB |
$5,237 |
189 |
--- |
8/29/25 |
--- |
$27.71 |
180,009 |
0.1 |
D |
--- |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
9/3/25 - 6:30:26 pm | ||||||||||||||
13 |
CEO,DIR |
OS |
$109,440 |
2,432 |
--- |
7/30/25 |
--- |
$45.00 |
179,820 |
-1.3 |
D |
10b |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
8/1/25 - 4:06:41 pm | ||||||||||||||
14 |
CEO,DIR |
OE |
$79,283 |
2,432 |
--- |
7/30/25 |
--- |
$32.60 |
182,252 |
1.4 |
D |
10b |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
8/1/25 - 4:06:41 pm | ||||||||||||||
15 |
CEO,DIR |
AS |
$48,416 |
1,160 |
--- |
7/11/25 |
--- |
$41.74 |
179,820 |
-0.6 |
D |
10b |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
7/15/25 - 8:54:09 pm | ||||||||||||||
16 |
DIR |
JB |
--- |
34,000 |
--- |
6/18/25 |
--- |
--- |
48,500 |
234.5 |
D |
R |
2836 |
Manufacturing |
Chemicals And Allied Products |
Biological Products, (No Disgnostic Substances)
|
6/23/25 - 7:20:50 pm | ||||||||||||||
17 |
CEO,DIR |
AS |
$4,525 |
140 |
--- |
3/11/25 |
--- |
$32.32 |
180,980 |
-0.1 |
D |
10b |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
3/13/25 - 4:45:26 pm | ||||||||||||||
18 |
CEO,DIR |
JB |
$12,328 |
437 |
--- |
2/28/25 |
--- |
$28.21 |
181,120 |
0.2 |
D |
--- |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
3/4/25 - 5:16:51 pm | ||||||||||||||
19 |
CEO,DIR |
AS |
$1,229,463 |
38,843 |
--- |
2/4/25 |
--- |
$31.65 |
180,683 |
-17.7 |
D |
10b |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
2/6/25 - 6:26:58 pm | ||||||||||||||
20 |
CEO,DIR |
S |
$429,655 |
13,242 |
--- |
1/31/25 |
--- |
$32.45 |
219,526 |
-5.7 |
D |
R |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
2/3/25 - 7:26:55 pm | ||||||||||||||
21 |
CEO,DIR |
JB |
--- |
25,372 |
--- |
1/30/25 |
--- |
--- |
232,768 |
12.2 |
D |
R |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
2/3/25 - 7:26:55 pm | ||||||||||||||
22 |
CEO,DIR |
S |
$1,091,444 |
33,445 |
--- |
1/16/25 |
--- |
$32.63 |
207,396 |
-13.9 |
D |
R |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
1/17/25 - 7:41:07 pm | ||||||||||||||
23 |
CEO,DIR |
JB |
--- |
73,448 |
--- |
1/15/25 |
--- |
--- |
240,841 |
43.9 |
D |
R |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
1/17/25 - 7:41:07 pm | ||||||||||||||
24 |
CEO,DIR |
AS |
$252,294 |
6,630 |
--- |
11/12/24 |
--- |
$38.05 |
167,393 |
-3.8 |
D |
10b |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
11/14/24 - 5:30:47 pm | ||||||||||||||
25 |
CEO,DIR |
JB |
$5,410 |
140 |
--- |
8/30/24 |
--- |
$38.64 |
174,023 |
0.1 |
D |
--- |
2834 |
Manufacturing |
Chemicals And Allied Products |
Pharmaceutical Preparations
|
9/4/24 - 9:43:19 pm | ||||||||||||||
26 |
DIR |
JB |
--- |
8,500 |
--- |
6/7/24 |
--- |
--- |
14,500 |
141.7 |
D |
R |
2836 |
Manufacturing |
Chemicals And Allied Products |
Biological Products, (No Disgnostic Substances)
|
6/11/24 - 6:46:17 pm | ||||||||||||||
|
|||||||||||||||||||||||||||
| |